Increase awareness of the FUEL-2 clinical trial!
Mezzion Pharmaceuticals is launching FUEL-2, the world’s largest Fontan clinical trial, as a part of its dedication to delivering hope to the Fontan community. FUEL-2 is a clinical study researching the efficacy and safety of Udenafil, an investigational medicine for teenagers 12-18 years of age who have had the Fontan procedure.
Social media graphics and sample social copy can be found below. Other downloadable materials, including an informational flyer and FAQs, can be found here.
Social Media Content
This content may be used across all social channels including Facebook, Instagram, LinkedIn, and X. Be sure to include the FUEL2study.com link and #FUEL2 hashtag along with your post!
We encourage you to use the suggested language, graphics and videos provided when posting on social media. This will help streamline uniform, relevant information about the clinical trial.
This page will be continuously updated with new copy and graphics – so be sure to keep checking for new content!
Graphic & Video Content
All materials available for download here.
Suggested Social Copy
X/Twitter
Exciting #research is underway for the Fontan community! #FUEL-2 is investigating a potential treatment to increase exercise capacity and energy for #Fontan teenagers.
Learn more at FUEL2study.com
X/Twitter
Interested in learning more about some of the latest clinical research for the #Fontan community?
Watch the video to learn more about the #FUEL-2 clinical trial and visit FUEL2study.com
Facebook/LinkedIn
Clinical trials are an important step in the development of treatment options.
Learn more about #FUEL-2, the world’s largest #Fontan clinical trial at FUEL2study.com
Facebook/LinkedIn
Hear from the investigators conducting the #FUEL-2 clinical trial to learn why this research is important for the #Fontan community.
For more information visit FUEL2study.com
Participating in a #clinicaltrial can help advance research and improve health outcomes for broader #CHD communities.
Learn more about #FUEL-2, the world’s largest #Fontan clinical trial: FUEL2study.com
Exciting research is underway for the #Fontan community! #FUEL-2 is investigating a potential treatment to increase exercise capacity and energy for Fontan teenagers.
Learn more at FUEL2study.com
Newsletter Content
This copy may be used for inclusion in email blasts, print and digital newsletters, and as for posting in private groups.
FUEL-2 Clinical Trial
Fontan teenagers and families: have you heard about the world’s largest Fontan clinical trial? Learn more about FUEL-2, clinical trial organized by Mezzion Pharmaceuticals to investigate the clinical efficacy and safety of Udenafil in teenagers 12-18 years old who have undergone the Fontan procedure.
To learn more about FUEL-2, including why the study is being conducted, what it entails, and to easily sign up for potential enrollment, visit FUEL2study.com
Website Content
This copy may be included on a clinical trials or latest research website page for example.
FUEL-2 Study
Fontan teenagers and families: learn more about FUEL-2, the world’s largest Fontan clinical trial! FUEL-2 is a clinical trial organized by Mezzion Pharmaceuticals investigating the clinical efficacy and safety of Udenafil in teenagers 12-18 years old who have undergone the Fontan procedure.
With 22 sites across the country enrolling more than 400 participants, this trial is an important step in the development of treatment options for the Fontan community. More information, including how to easily sign up for potential enrollment can be found at FUEL2study.com.
